Recent Updates
Recently added Catalysts
ICCM Neutral Sentiment Score: 60/100

Dear IceCure Medical Ltd. Shareholders: We cordially invite you to attend the Special General Meeting of Shareholders of IceCure Medical Ltd. (the " Meeting "), to be held on Thursday

Key Takeaway: IceCure Medical Ltd. has announced a Special General Meeting for shareholders scheduled on May 15, 2025. At this meeting, shareholders will vote on several agenda items, including the renewal of the Compensation Policy and equity-based compensation grants for key executives. The board of directors is urging shareholders to vote in favor of all proposals outlined in the notice for the meeting. Only shareholders on record as of April 16, 2025, are eligible to vote or appoint proxies for representation at the meeting.

Market Sentiment Analysis

POSITIVE FACTORS

  • The meeting invites shareholders to participate in governance.
  • The board of directors unanimously recommends voting FOR the proposals.
  • Key personnel compensation packages are being proposed, indicating growth and investment in leadership.

Full Press Release Details

Dear IceCure Medical Ltd. Shareholders:
We cordially invite you to
attend the Special General Meeting of Shareholders of IceCure Medical Ltd. (the "Meeting"), to be held on Thursday,
May 15, 2025 at 16:00 Israel time, or at any adjournment or postponement thereof, at the Company's offices at 7 Ha'Eshel St.,
Caesarea, 3079504, Israel.
At the Meeting, shareholders
will be asked to consider and vote on the matters listed in the enclosed Notice of Special General Meeting of Shareholders. Our board
of directors recommends that you vote FOR each of the Proposals listed in the Notice.
Only shareholders of record
at the close of business on Wednesday, April 16, 2025, are entitled to be provided with notice of and to vote at the Meeting either in
person or by appointing a proxy to vote in their stead at the Meeting as detailed in the Notice.
We look forward to greeting
as many of you as can attend the Meeting.
Sincerely,
/s/ Ron Mayron
Ron Mayron
Chairman of the Board of Directors
April 10, 2025
of SPECIAL General Meeting of shareholders
Notice is hereby given that a Special General
Meeting of Shareholders (the "Meeting") of IceCure Medical Ltd. (the "Company") will be held on
Thursday, May 15, 2025 at 16:00 Israel time, or at any adjournment or postponement thereof, at the Company's offices at 7 Ha'Eshel
St., Caesarea, 3079504.
The following matters are on the agenda for
1. To approve the renewal of the Company's Compensation Policy;
2. To approve an equity-based compensation grant to Mr. Eyal Shamir, the Company's Chief Executive Officer and Director;
4. To approve an equity-based compensation grant to Mr. Yang Huang, a Director of the Company;
5. To approve an amendment to the services agreement of Mr. Ron Mayron, the Company's Chairman of the Board of Directors.
Board Recommendation
Our board of directors (the "Board of
Directors") unanimously recommends that you vote "FOR" each of the above proposed resolutions, which are
described in the attached proxy statement.
Shareholders of record at the close of business
on Wednesday, April 16, 2025 (the "Record Date"), are entitled to be provided with notice and to vote at the Meeting
either in person or by appointing a proxy to vote in their stead at the Meeting (as detailed below).
A form of proxy for use at the Meeting is attached
to the proxy statement and a voting instruction form, together with a return envelope, will be sent to holders of Company's ordinary
shares, no par value (the "Ordinary Shares"). By appointing "proxies," shareholders may vote at the Meeting
regardless of whether they attend.
Subject to applicable law and the rules of the
Nasdaq Stock Market, in the absence of instructions, the Ordinary Shares represented by properly executed and received proxies will be
voted "FOR" each of the proposed resolutions to be presented at the Meeting for which the Board of Directors recommends a
Shareholders may revoke their proxies or voting
instruction form (as applicable) in accordance with Section 9 of the Israeli Companies Law, 5759-1999 regulations (proxy and positions
Shareholders registered directly with the transfer agent
If your shares are registered directly in your
name with our transfer agent, VStock Transfer, LLC, you are considered, with respect to those shares, to be the shareholder of record.
In such case, these proxy materials are being sent directly to you. As the shareholder of record, you have the right to use the proxy
card included with this Proxy Statement to grant your voting proxy directly to Ronen Tsimerman, Chief Financial Officer of the Company,
and/or Eyal Shamir, Chief Executive Officer of the Company, or to vote in person at the Meeting.
Shareholders of beneficial owner
If your shares are held through a bank, broker
or other nominee, they are considered to be held in "street name" and you are the beneficial owner with respect to those shares.
A beneficial owner as of the Record Date has the right to direct the bank, broker or nominee how to vote shares held by such beneficial
owner at the Meeting and must also provide the Company with a copy of their identity card, passport or certification of incorporation,
as the case may be. If your shares are held in "street name" as of the Record Date, these proxy materials are being forwarded
to you by your bank, broker or nominee who is considered, with respect to those shares, as the shareholder of record, together with a
voting instruction card for you to use in directing the bank, broker or nominee how to vote your shares. Because a beneficial owner is
not a shareholder of record, you may not vote those shares directly at the Meeting unless you obtain a "legal proxy" from
the bank, broker or other nominee that holds your shares directly, giving you the right to vote the shares at the Meeting. Absent specific
instructions from the beneficial owner of the shares, brokers are not allowed to exercise their voting discretion, among other things,
with respect to the election of directors or any matter that relates to executive compensation and a "broker non-vote" occurs
with respect to such uninstructed shares. Therefore, it is important for a shareholder that holds Ordinary Shares through a bank or broker
to instruct its bank or broker how to vote its shares, if the shareholder wants its shares to count for all proposals.
Sincerely,
/s/ Ron Mayron
Ron Mayron
Chairman of the Board of Directors
April 10, 2025

Frequently Asked Questions

When is the IceCure Medical Special Meeting scheduled?

The Special General Meeting is on May 15, 2025, at 16:00 Israel time.

How can shareholders vote at the IceCure Meeting?

Shareholders can vote in person or appoint a proxy to vote on their behalf.

What is on the agenda of the Special Meeting?

The agenda includes approving compensation policies and grants for executives.

Who can vote at the IceCure Medical Meeting?

Only shareholders of record on April 16, 2025, can vote at the Meeting.

How can beneficial owners vote their shares?

Beneficial owners must instruct their broker or obtain a legal proxy to vote.

Last updated: Apr 10, 2025